Association between colorectal polyps and hypertension treatment (Q40554318)

21 September 2017

Association between colorectal polyps and hypertension treatment (English)

1 reference

21 September 2017

9

Kazuhiko Koike

1 reference

21 September 2017

Yoshitaka Watanabe

1

1 reference

21 September 2017

Yutaka Yamaji

2

1 reference

21 September 2017

Yuka Kobayashi

3

1 reference

21 September 2017

Shuntaro Yoshida

4

1 reference

21 September 2017

Takafumi Sugimoto

5

1 reference

21 September 2017

Atsuo Yamada

6

1 reference

21 September 2017

Hirotsugu Watabe

7

1 reference

21 September 2017

Yoshihiro Hirata

8

1 reference

21 September 2017

10 September 2015

1 reference

Journal of Digestive Diseases

21 September 2017

1 reference

21 September 2017

16

1 reference

21 September 2017

649-655

1 reference

21 September 2017

11

1 reference

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

The concept and treatment of locomotive syndrome: its acceptance and spread in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Celecoxib for the prevention of colorectal adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Beta blocker use and colorectal cancer risk: population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Lack of an association between angiotensin receptor blocker based therapy and increased risk of cancer: evidence from large observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

A randomized controlled trial of sodium phosphate tablets and polyethylene glycol solution for polyp detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

The effect of body weight reduction on the incidence of colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Which, if any, antihypertensive agents cause cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Antihypertensive drug use and the risk of prostate cancer (Canada)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

The renin-angiotensin system and cancer: old dog, new tricks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Risk factors for colorectal neoplasms based on colonoscopy and pathological diagnoses of Chinese citizens: a multicenter, case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Calcium-channel blockers and risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12289

21 January 2018

Identifiers

DOI

10.1111/1751-2980.12289

1 reference

21 September 2017

1 reference